Novel Molecular Targets for Mood Disorders and Psychosis : Proceedings of a Workshop

Novel Molecular Targets for Mood Disorders and Psychosis Proceedings of a Workshop

Mood disorders - including depression and bipolar disorder - are common, disabling, and potentially lethal disorders, characterized by a shortened lifespan from comorbid medical illness and rising suicide rates. Medications for these conditions have been shown to be insufficiently effective in the m...

Descripción completa

Detalles Bibliográficos
Autores Corporativos: National Academies of Sciences, Engineering, and Medicine, contributor (contributor), Division, Health and Medicine, contributor, Policy, Board on Health Sciences, contributor, Disorders, Forum on Neuroscience and Nervous System, contributor
Otros Autores: Bain, Lisa J., author (author), Division, Health and Medicine (-), Policy, Board on Health Sciences, Disorders, Forum on Neuroscience and Nervous System, Stroud, Clare, Matney, Chanel, Bain, Lisa J.
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press 2021.
Materias:
Affective disorders > Treatment.
Drug development.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009641233706719
Tabla de Contenidos:
  • Introduction and Background
  • 2 Current Drug Development Landscape and Limitations of Molecular Targets for Mood Disorders and Psychosis
  • 3 Targeting Glutamate Receptors for Treatment-Resistant Depression
  • 4 Targeting GABA Receptors to Treat Postpartum Depression
  • 5 Emerging Drug Targets
  • 6 Regulatory Considerations for the Next Generation of Psychiatric Drugs
  • 7 Ethical and Legal Principles Related to the Clinical Use of Psychoactive Drugs
  • 8 Potential Next Steps and Future Opportunities.

Ejemplares similares